LC
ABBV icon

Luminist Capital’s AbbVie ABBV Stock Holding History

Luminist Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21
Closed -$4.88K – 111
2025
Q4 		$4.88K Sell
21
-24
-53% -$5.47K 0.01% 182
2025
Q3 		$11K Buy
45
+24
+114% +$4.89K 0.01% 172
2025
Q2 		$4K Hold
21
– – ﹤0.01% 239
2025
Q1 		$4.3K Hold
21
– – ﹤0.01% 181
2024
Q4 		$3.67K Buy
+21
New +$3.86K 0.01% 171

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Luminist Capital's ABBV Position: Q1 2026 in Review

Luminist Capital sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 21 shares — an estimated $4.88K sold.

Luminist Capital first reported a position in ABBV in Q4 2024 and held it in 5 quarters. The position peaked at $11K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Luminist Capital reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Luminist Capital sold 21 AbbVie shares in Q1 2026, an estimated $4.88K.
  • Luminist Capital first reported a position in AbbVie in Q4 2024 and held it in 5 quarters.
  • Luminist Capital's AbbVie position peaked at $11K in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Luminist Capital's 13F filing for Q1 2026, filed 24 Apr 2026.